Anti-inflammatory effects of mitogen-activated protein kinase kinase inhibitor U0126 in an asthma mouse model

Journal of Immunology

Volumn 172, Issue 11, 2004, Pages 7053-7059

  Duan, Wei ^a   Chan, Jasmine H P ^a   Wong, Chui Hong ^a   Leung, Bernard P ^b   Wong, W S Fred ^a,c  

^a NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^b TAN TOCK SENG HOSPITAL   (Singapore)

^c NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; EOTAXIN; IMMUNOGLOBULIN E; IMMUNOGLOBULIN G1; INTERLEUKIN 13; INTERLEUKIN 4; INTERLEUKIN 5; MACROGOL; MITOGEN ACTIVATED PROTEIN KINASE INHIBITOR; OVALBUMIN; UO 126; VASCULAR CELL ADHESION MOLECULE 1;

AIRWAY; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ARTICLE; ASTHMA; BRONCHUS HYPERREACTIVITY; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFECT; ENZYME INHIBITION; ENZYME LINKED IMMUNOSORBENT ASSAY; HISTOLOGY; LUNG LAVAGE; MOUSE; NONHUMAN; PRIORITY JOURNAL; WESTERN BLOTTING;

EID: 2442712697     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.172.11.7053     Document Type: Article

References (46)

1. Busse, W. W., and R. F. Lemanske, Jr. 2001. Asthma. N. Engl. J. Med. 344:350.
2. Herrick, C. A., and K. Bottomly. 2003. To respond or not to respond: T cells in allergic asthma. Nat. Rev. Immunol. 3:1.
3. Wynn, T. A. 2003. IL-13 effector functions. Annu. Rev. Immunol. 21:425.
4. Lukacs, N. W. 2001. Role of chemokines in the pathogenesis of asthma. Nat. Rev. Immunol. 1:108.
5. Wills-Karp, M. 1999. Immunologic basis of antigen-induced airway hyperresponsiveness. Annu. Rev. Immunol. 17:255.
6. Chang, L., and M. Karin. 2001. Mammalian MAP kinase signaling cascades. Nature 410:37.
7. Nel, A. E. 2002. T-cell activation through the antigen receptor. 1. Signaling components, signaling pathways, and signal integration at the T-cell antigen receptor synapse. J. Allergy Clin. Immunol. 109:758.
8. Jacob, A., D. Cooney, M. Pradhan, and K. M. Coggeshall. 2002. Convergence of signaling pathways on the activation of ERK in B cells. J. Biol. Chem. 277:23420.
9. Gauld, S. B., J. M. Dal Porto, and J. C. Cambier. 2002. B cell antigen receptor signaling: roles in cell development and disease. Science 296:1641.
10. Nadler, M. J., S. A. Matthews, H. Turner, and J. P. Kinet. 2000. Signal transduction by the high-affinity immunoglobulin E receptor FcεRI: coupling form to function. Adv. Immunol. 76:325.
11. Pazdrak, K., B. Olszewska-Pazdrak, S. Stafford, R. P. Garofalo, and R. Alam. 1998. Lyn, Jak2, and Raf-1 kinases are critical for the antiapoptotic effect of interleukin 5, whereas only Raf-1 kinase is essential for eosinophil activation and degranulation. J. Exp. Med. 188:421.
12. Boehme, S. B., S. K. Sullivan, P. D. Crowe, M. Santos, P. J. Conlon, P. Sriramarao, and K. B. Bacon. 1999. Activation of mitogen-activated protein kinase regulates eotaxin-induced eosinophil migration. J. Immunol. 163:1611.
13. Kumar, A., S. Lnu, R. Malya, D. Barron, J. Moore, D. B. Corry, and A. M. Boriek. 2003. Mechanical stretch activates nuclear factor-κB, activator protein-1, and mitogen-activated protein kinases in lung parenchyma: implications in asthma. FASEB J. 17:1800.
14. Tsang, F., A. H. M. Koh, W. L. Ting, P. T. H. Wong, and W. S. F. Wong. 1998. Effects of mitogen-activated protein kinase kinase inhibitor PD 098059 on antigen challenge of guinea-pig airways in vitro. Br. J. Pharmacol. 125:61.
15. Favata, M. F., K. Y. Horiuchi, E. J. Manos, A. J. Daulerio, D. A. Stradley, W. S. Feeser, D. E. Van Dyk, W. J. Pitts, R. A. Earl, F. Hobbs, et al. 1998. Identification of a novel inhibitor of mitogen-activated protein kianse kinase. J. Biol. Chem. 273:18623.
16. Garside, P., M. Steel, E. A. Worthey, A. Satoskar, J. Alexander, H. Bluethmann, F. Y. Liew, and A. M. Mowat. 1995. T helper 2 cells are subject to high dose oral tolerance and are not essential for its induction. J. Immunol. 154:5649.
17. Myou, S., A. R. Leff, S. Myo, E. Boetticher, J. Tong, A. Y. Meliton, J. Liu, N. M. Munoz, and X. Zhu. 2003. Blockade of inflammation and airway hyper-responsiveness in immune-sensitized mice by dominant-negative phosphoinositide 3-kinase-TAT. J. Exp. Med. 198:1573.
18. Tanaka, H., T. Masuda, S. Tokuoka, M. Komai, K. Nagao, Y. Takahashi, and H. Nagai. 2001. The effect of allergen-induced airway inflammation on airway remodeling in a murine model of allergic asthma. Inflamm. Res. 50:616.
19. Hamelmann, E., J. Schwarze, K. Takeda, A. Oshiba, G. L. Larsen, C. G. Irvin, and E. W. Gelfand. 1997. Noninvasive measurement of airway responsiveness in allergic mice using barometric plethysmography. Am. J. Respir. Crit. Care Med. 156:766.
20. Larche, M., D. S. Robinson, and A. B. Kay. 2002. The role of T lymphocytes in the pathogenesis of asthma. J. Allergy Clin. Immunol. 111:450.
21. + T cells. J. Immunol. 170:2427.
22. Pahl, A., M. Zhang, H. Kuss, I. Szelenyi, and K. Brune. 2002. Regulation of IL-13 synthesis in human lymphocytes: implications for asthma therapy. Br. J. Pharmacol. 135:1915.
23. Puig-Kroger, A., M. Relloso, O. Fernandez-Capetillo, A. Zubiaga, A. Silva, C. Bernabeu, and A. L. Corbi. 2001. Extracellular signal-regulated protein kinase signaling pathway negatively regulates the phenotypic and functional maturation of monocyte-derived human dendritic cells. Blood 98:2175.
24. Reynold, A. A., Jr. 2002. Airway smooth muscle: an immunomodulatory cell. J. Allergy Clin. Immunol. 110:S269.
25. Laporte, J. C., P. E. Moore, S. Baraldo, M.-H. Jouvin, T. L. Church, I. N. Schwartzman, R. A. Panettieri, Jr., J. P. Kinet, and S. A. Shore. 2001. Direct effects of interleukin-13 on signaling pathways for physiological responses in cultured human airway smooth muscle cells. Am. J. Respir. Crit. Care Med. 164:141.
26. Hirst, S. J., M. P. Hallsworth, Q. Peng, and T. H. Lee. 2002. Selective induction of eotaxin release by interleukin-13 or interleukin-4 in human airway smooth muscle cells is synergistic with interleukin-1β and is mediated by the interleukin-4 receptor α-chain. Am. J. Respir. Crit. Care Med. 165:1161.
27. Moore, P. E., T. L. Church, D. D. Chism, R. A. Panettieri, Jr., and S. A. Shore. 2002. IL-13 and IL-4 cause eotaxin release in human airway smooth muscle cells: a role for ERK. Am. J. Physiol. Lung Cell Mol. Physiol. 282:L847.
28. Cui, C. H., T. Adachi, H. Oyamada, Y. Kamada, T. Kuwasaki, Y. Yamada, N. Saito, H. Kayaba, and J. Chihara. 2002. The role of mitogen-activated protein kinases in eotaxin-induced cytokine production from bronchial epithelial cells. Am. J. Respir. Cell Mol. Biol. 26:329.
29. Lorentz, A., I. Klopp, T. Gebhardt, M. P. Manns, and S. C. Bischoff. 2003. Role of activator protein 1, nuclear factor-κB, and nuclear factor of activated T cells in IgE receptor-mediated cytokine expression in mature human mast cells. J. Allergy Clin. Immunol. 111:1062.
30. Langdon, C., C. Kerr, L. Tong, and C. D. Richards. 2003. Oncostatin M regulates eotaxin expression in fibroblasts and eosinophilic inflammation in C57BL/6 mice. J. Immunol. 170:548.
31. Jia, G.-Q., J. A. Gonzalo, A. Hidalgo, D. Wagner, M. Cybulsky, and J. C. Gutierrez-Ramos. 1999. Selective eosinophil transendothelial migration triggered by eotaxin via modulation of Mac-1/ICAM-1 and VLA-4/VCAM-1 interactions. Int. Immunol. 11:1.
32. Li, L., Y. Xia, A. Nguyen, Y. H. Lai, L. Feng, T. R. Mosmann, and D. Lo. 1999. Effects of Th2 cytokines on chemokine expression in the lung: IL-13 potently induces eotaxin expression by airway epithelial cells. J. Immunol. 162:2477.
33. Kampen, G. T., S. Stafford, T. Adachi, T. Jinquan, S. Quan, J. A. Grant, P. S. Skov, L. K. Poulsen, and R. Alam. 2000. Eotaxin induces degranulation and chemotaxis of eosinophils through the activation of ERK2 and p38 mitogen-activated protein kinases. Blood 95:1911.
34. + T cell-dependent airway mucus production occurs in response to IL-5 expression in lung. Am. J. Physiol. Lung Cell Mol. Physiol. 282:L1066.
35. Cohn, L., R. J. Homer, A. Marinov, J. Rankin, and K. Bottomly. 1997. Induction of airway mucus production by T helper 2 (Th2) cells: a critical role for interleukin 4 in cell recruitment but not mucus production. J. Exp. Med. 186:1737.
36. Zhu, Z., R. J. Homer, Z. Wang, Q. Chen, G. P. Geba, J. Wang, Y. Zhang, and J. A. Elias. 1999. Pulmonary expression of interleukin-13 causes inflammation, mucus hypersecretion, subepithelial fibrosis, physiologic abnormalities, and eotaxin production. J. Clin. Invest. 103:779.
37. Atherton, H. C., G. Jones, and H. Danahay. 2003. IL-13-induced changes in the goblet cell density of human bronchial epithelial cell cultures: MAP kinase and phosphatidylinositol 3-kinase regulation. Am. J. Physiol. Lung Cell Mol. Physiol. 285:L730.
38. Richards, J. D., S. H. Dave, C. H. G. Chou, A. A. Mamchak, and A. L. DeFranco. 2001. Inhibition of the MEK/ERK signaling pathway blocks a subset of B cell responses to antigen. J. Immunol. 166:3855.
39. Emson, C. L., S. E. Bell, A. Jones, W. Wisden, and A. N. J. McKenzie. 1998. Interleukin (IL)-4-independent induction of immunoglobulin (Ig)E, and perturbation of T cell development in transgenic mice expressing IL-13. J. Exp. Med. 188:399.
40. Kawakami, T., and S. J. Galli. 2002. Regulation of mast-cell and basophil function and survival by IgE. Nat. Rev. Immunol. 2:773.
41. Fernandes, D. J., R. W. Mitchell, O. Lakser, M. Dowell, A. G. Stewart, and J. Solway. 2003. Do inflammatory mediators influence the contribution of airway smooth muscle contraction to airway hyperresponsiveness in asthma? J. Appl. Physiol. 95:844.
42. Gleich, G. J. 2000. Mechanisms of eosinophil-associate inflammation. J. Allergy Clin. Immunol. 105:651.
43. Foster, P. S., S. P. Hogan, A. J. Ramsay, K. I. Matthaei, and I. G. Young. 1996. Interleukin 5 deficiency abolishes eosinophilia, airways hyperreactivity, and lung damage in a mouse asthma model. J. Exp. Med. 183:195.
44. Vargaftig, B. B., and M. Singer. 2003. Leukotrienes mediate murine bronchopulmonary hyperreactivity, inflammation, and part of mucosal metaplasia and tissue injury induced by recombinant murine interleukin-13. Am. J. Respir. Cell Mol. Biol. 28:410.
45. To, Y., M. Dohi, R. Tanaka, A. Sato, K. Nakagome, and K. Yamamoto. 2001. Early interleukin 4-dependent response can induce airway hyperreactivity before development of airway inflammation in a mouse model of asthma. Lab. Invest. 81:1385.
46. Taube, C., C. Duez, Z. H. Cui, K. Takeda, Y. H. Rha, J. W. Park, A. Balhorn, D. D. Donaldson, A. Dakhama, and E. W. Gelfand. 2002. The role of IL-13 in established allergic airway disease. J. Immunol. 169:6482.